Point of care testing (POCT)
» BIOEASY » Point of care testing (POCT)
- COVID-19
- Diabetes
- In-ammation
- Cardiac Markers
- Coagulation
- Fertility
- Tumor Marker
- Thyroid Hoemones
- Sex Hormones
- Others
Time-resolved Fluorescence Immunoassay Analyzer
Time-resolved Fluorescence Immunoassay Analyzer is a rapid, quantitative instrument that tests quantitative items such as cardiac markers inflammation, hormone, diabetes, etc.
- Ultra high sensitivity
- Self-Calibration
- Android system
- LIS/HIS connectivity
Innovative
It’s innovative, comprehensive and absolutely necessary for the quantitative tests. It is an automatic in-vitro diagnostic device that measures the concentration of analytes,contained in blood or other samples, in quantitative ways.
Sensitive
Time-resolved fluorescence immunoassay (TRFIA) uses time-resolved techniques to measure fluorescence,combines long decay lifetime markers with time-resolved fluorescence, effectively eliminating non-specific fluorescence interference and greatly improving analytical sensitivity.
Bottleneck Factor
Different samples of endogenous substances interfere with fluorescent signals,
affecting the test results
Some biomarkers require lower detection concentrations
POCT requires more convenient quality control methods to ensure accurate test results
Poor visible or fluorescent signal stability,
short detection window
Collecting the surface of t he test card and the optical signals present by all the particles, it is currently difficult to implement
With the innovation of lmmunochemical POCT technology, TRFIA came into being.
lmmunochemical POCT methodology
FLUORESCENCE IMMUNOASSAY ANALYZER
Existing POCT dry fluorescence methods are difficult to achieve accurate and sensitive detection requirements for clinical samples.
With the innovation of lmmunochemical POCT technology, TRFIA came into being.
-
Bioeasy
Time-resolved Fluorescence Immunoassay Analyzer
Time-resolved Fluorescence Immunoassay Analyzer is a rapid, quantitative instrument that tests quantitative items such as cardiac markers inflammation, hormone, diabetes, etc. -
Bioeasy
Bioeasy – Point of care testing
Bioeasy is a biotechnology company focused on the research and developm ent of POCT. We dedicate to provide simple, reliable, quality assurancable and aff ordable POCT solutions.
Time-resolved Fluorescence Immunoassay Analyzer
Product name
lmmunofluorescence Analyzer
Product name
lmmunofluorescence Analyzer
Sample type
Whool blood / serum / plasma / urine, etc.
Test channel
Single channel,automatic
Product Range for POCT
Product |
Items |
Sample |
Volume |
Time |
Clinical Reference |
Range |
Quality |
COVID-19 |
COVID-19 Antigen |
Nasal swab / Deep sputum |
/ |
10 mins |
Negative |
Negative / Positive |
CE |
Diabets |
HbA1c |
WB |
5µL |
5 mins |
4%-6% |
2%-14% |
CE ifcc NGSP |
Inflammation |
hsCRP/CRP |
WB/S/P |
5µL |
3 mins |
hsCRP |
0.5-200mg/L |
CE |
PCT |
WB/S/P |
50µL |
15 mins |
<0.1 ng/ml |
0.1-1 OOOng/mL |
CE |
|
CRP/SAA |
WB/S/P |
5µL |
3 mins |
hsCRP<1.0mg L CRP<10mg LSAA<10mg/L |
CRP:0.5-200mg/L SAA:5-300mg/L |
CE |
|
PCT/IL-6 |
WB/S/P |
50µL |
15 mins |
PCT < 0.1 ng/ml IL-6<7pg/ml |
PCT:0.1-1 OOOng/mL IL-6:7-1 OOOOOpg/mL |
CE |
|
Cardiac Markers |
cTnL |
WB/S/P |
75µL |
15 mins |
<0.3 ng/ml |
0.1-400 ng/ml |
CE |
CK-MB |
WB/S/P |
30µL |
15 mins |
<5 ng/ml |
1-1000 ng/ml |
CE |
|
Myo |
WB/S/P |
8µL |
15 mins |
<80 ng/ml |
5- 5000ng/ml |
CE |
|
cTnl/Myo/CK-MB |
WB/S/P |
30µL |
15 mins |
<75aged:<300pg/ml >75aged:<450pg/ml |
100–350000 pg/mL |
CE |
|
NT-proBNP |
WB/S/P |
75µL |
15 mins |
cTnl<0.3ng/mL Myo<80ng/ml CKMB<5ng/ml |
CTnl:0.1-400ng/mL Myo: 5-5000ng/ml CK-MB:1 -1OOOng/mL |
CE |
|
Coagulation |
D-Dimer |
WB/P |
10µL |
5 mins |
<0. 5mg/L |
0.1-100mg/L |
CE |
Fertility |
B-HCG |
WB/S/P |
10µL |
15 mins |
<5 mlU/mL |
5-2000000mlU/mL |
CE |
AMH |
WB/S/P |
75µL |
15 mins |
2-7 ng/ml |
0.1 -16ng/ml |
CE |
|
Tumor Maker |
PSA |
WB/S/P |
35µL |
15 mins |
0-4.0 ng/ml |
2-1 OOng/mL |
CE |
FPSA |
WB/S/P |
75µL |
15 mins |
< 1 ng/ml |
0. 2-30ng/ml |
CE |
|
Thyroid Hoemones |
T3 |
WB/S/P |
75µL |
15 mins |
1.23-3.07n mol/L (0.8-2.0ng/ml) |
0.61-9 . 22nmol/L |
CE |
T4 |
WB/S/P |
75µL |
15 mins |
66 -181n mol/L 66-181n mol/L |
0.61-9 . 22nmol/L |
CE |
|
Ft3 |
WB/S/P |
75µL |
15 mins |
2.8-7.1p mol/L (1.82-4.61pg/ml) |
0.40-50.00pmol/L(0.26-32.55pg/ml) |
CE |
|
Ft4 |
WB/S/P |
75µL |
15 mins |
12-22pmol/L (0.94-1.72ng/dl) |
1.00-1 OOpmol/L(0.078-7. 77ng/dl) |
CE |
|
TSH |
WB/S/P |
75µL |
15 mins |
0.3 -4.2mlU/L |
0.1-1 OOOmlU/L |
CE |
|
PTH* |
WB/S/P |
75µL |
15 mins |
15-65pg/ml |
5-1 OOOpg/mL |
||
Sex Hormones |
LH |
WB/S/P |
75µL |
15 mins |
Malenormalrange:1. 70-8.60mlU/m L Female Follicularphase: 2.95-13.65mlU/ml Ovulation:13.65-95. 75 ml U/ml Lutealphase:1.25-11.00mlU/m LMenopause :8.24-55 .23m I U/ml |
1-100mlU/mL |
|
FSH* |
WB/S/P |
75µL |
15 mins |
5-40mlU/ml |
1-100mlU/mL |
||
PRL* |
WB/S/P |
75µL |
15 mins |
Male:3.45-17.42ng/mlFemale(non-pregnant): 4.60 -25.07ng/ml |
1-200ng/ml |
||
TES* |
WB/S/P |
75µL |
15 mins |
Male:9.45-37.45nmol/LFemale:0. 21-3 .01 nmol/L |
0.1-1 OOnmol/L |
||
PROG’ |
WB/S/P |
75µL |
15 mins |
Malenormal range<1.4-1.5ng/ml Female Follicularphase<1.4-1.9ng/ml Ovulation<1.4 12.0ng/ml Lutealphase:1. 7- 28 . 7ng/ml Menopause< 1.4ng/m L Pregnancy(<12 weeks ):11.0-53.0ng/ml Pregnancy(12- 24weeks):21.5-60.0 ng/ml |
1.4-60 ng/ml |
||
E2* |
WB/S/P |
75µL |
15 mins |
Pre-ovulationperiod:48-521 pmol/L Ovulation period: 70-183 5pmol/L Late-ovulation period: 272-793pmol/L |
10-5000pmol/L |
||
Other |
Vitamin D |
WB/S/P |
75µL |
15 mins |
30 -1 OOng/mL |
5-1 OOng/mL |
CE |